Home

banc terre en friche Facile à arriver cd8 cancer markers carbone Journal champion

Macrophages impede CD8 T cells from reaching tumor cells and limit the  efficacy of anti–PD-1 treatment | PNAS
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment | PNAS

NR4A and TOX Transcription Factors Mediate CD8+ T Cell Exhaustion
NR4A and TOX Transcription Factors Mediate CD8+ T Cell Exhaustion

CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients  Using Immunotherapy Targeting Tumor-Associated Antigens: Molecular Therapy
CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens: Molecular Therapy

Stem-like CD8 T cells mediate response of adoptive cell immunotherapy  against human cancer | Science
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer | Science

Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment -  ScienceDirect
Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment - ScienceDirect

How to evaluate the immune status of lung cancer patients before  immunotherapy | European Respiratory Society
How to evaluate the immune status of lung cancer patients before immunotherapy | European Respiratory Society

CD8+ T cell states in human cancer: insights from single-cell analysis |  Nature Reviews Cancer
CD8+ T cell states in human cancer: insights from single-cell analysis | Nature Reviews Cancer

Distinct epigenetic features of tumor-reactive CD8+ T cells in colorectal  cancer patients revealed by genome-wide DNA methylation analysis | Genome  Biology | Full Text
Distinct epigenetic features of tumor-reactive CD8+ T cells in colorectal cancer patients revealed by genome-wide DNA methylation analysis | Genome Biology | Full Text

Frontiers | Regulation of CD8+ T Cells and Antitumor Immunity by Notch  Signaling
Frontiers | Regulation of CD8+ T Cells and Antitumor Immunity by Notch Signaling

Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as  predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer  | British Journal of Cancer
Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer | British Journal of Cancer

Spatial determinants of CD8+ T cell differentiation in cancer: Trends in  Cancer
Spatial determinants of CD8+ T cell differentiation in cancer: Trends in Cancer

The good (T cells), the bad (T cells), and the ugly (tumor)
The good (T cells), the bad (T cells), and the ugly (tumor)

A unified atlas of CD8 T cell dysfunctional states in cancer and infection  - ScienceDirect
A unified atlas of CD8 T cell dysfunctional states in cancer and infection - ScienceDirect

Fates of CD8+ T cells in Tumor Microenvironment - ScienceDirect
Fates of CD8+ T cells in Tumor Microenvironment - ScienceDirect

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in  human solid tumors | Nature Communications
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors | Nature Communications

Automated assessment of CD8+ T-lymphocytes and stroma fractions complement  conventional staging of colorectal cancer - eBioMedicine
Automated assessment of CD8+ T-lymphocytes and stroma fractions complement conventional staging of colorectal cancer - eBioMedicine

JCI Insight - CX3CR1–CD8+ T cells are critical in antitumor efficacy but  functionally suppressed in the tumor microenvironment
JCI Insight - CX3CR1–CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment

Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible  mechanism for immune impairment | Cellular & Molecular Immunology
Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment | Cellular & Molecular Immunology

CD8+ T cell differentiation and dysfunction in cancer | Nature Reviews  Immunology
CD8+ T cell differentiation and dysfunction in cancer | Nature Reviews Immunology

Cytotoxic CD8+ T cells in cancer and cancer immunotherapy | British Journal  of Cancer
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy | British Journal of Cancer

IJMS | Free Full-Text | The Evolving Role of CD8+CD28− Immunosenescent T  Cells in Cancer Immunology
IJMS | Free Full-Text | The Evolving Role of CD8+CD28− Immunosenescent T Cells in Cancer Immunology

PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical  outcome in hepatocellular carcinoma | Journal for ImmunoTherapy of Cancer
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma | Journal for ImmunoTherapy of Cancer

Frontiers | Therapeutic Cancer Vaccines—T Cell Responses and Epigenetic  Modulation
Frontiers | Therapeutic Cancer Vaccines—T Cell Responses and Epigenetic Modulation

Intratumoral CD8+ T cells with stem cell–like properties: Implications for  cancer immunotherapy | Science Translational Medicine
Intratumoral CD8+ T cells with stem cell–like properties: Implications for cancer immunotherapy | Science Translational Medicine

Stem-like CD8+ T cells cozy up within tumors before launching an attack
Stem-like CD8+ T cells cozy up within tumors before launching an attack

The expression of phenotypic Treg markers in the CD8+ T cells from... |  Download Scientific Diagram
The expression of phenotypic Treg markers in the CD8+ T cells from... | Download Scientific Diagram